D. F. Larson

931 total citations
18 papers, 743 citations indexed

About

D. F. Larson is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, D. F. Larson has authored 18 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in D. F. Larson's work include Cardiovascular Function and Risk Factors (6 papers), Cardiac Valve Diseases and Treatments (4 papers) and Congenital Heart Disease Studies (4 papers). D. F. Larson is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Cardiac Valve Diseases and Treatments (4 papers) and Congenital Heart Disease Studies (4 papers). D. F. Larson collaborates with scholars based in United States and Brazil. D. F. Larson's co-authors include Diane H. Russell, Bruce E. Magun, Lynn M. Matrisian, B. T. Poulos, Ruthann Kibler, S Horowitz, David J. Sahn, Lilliam M. Valdes‐Cruz, Daniel C. Fisher and Stanley J. Goldberg and has published in prestigious journals such as Circulation, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

D. F. Larson

16 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. F. Larson United States 10 298 168 132 125 116 18 743
Asuman Kaftan Türkiye 13 376 1.3× 161 1.0× 42 0.3× 59 0.5× 57 0.5× 30 747
Masaru Inoue Japan 20 363 1.2× 119 0.7× 135 1.0× 54 0.4× 112 1.0× 40 868
Daniel Schmitz Germany 14 69 0.2× 132 0.8× 52 0.4× 174 1.4× 73 0.6× 52 652
Rosaire Gray United Kingdom 13 258 0.9× 72 0.4× 85 0.6× 200 1.6× 16 0.1× 25 652
Richard S. A. Tindall United States 16 147 0.5× 182 1.1× 56 0.4× 47 0.4× 58 0.5× 29 1.3k
T. Gibson United Kingdom 13 235 0.8× 145 0.9× 55 0.4× 124 1.0× 153 1.3× 26 799
Yuya Yamada Japan 16 85 0.3× 187 1.1× 191 1.4× 174 1.4× 52 0.4× 80 794
Anna Kuryliszyn-Moskal Poland 16 51 0.2× 112 0.7× 98 0.7× 55 0.4× 70 0.6× 70 908
Ernest H. Picard United States 8 166 0.6× 99 0.6× 28 0.2× 107 0.9× 36 0.3× 14 728
ROSE T. T. YEUNG China 22 67 0.2× 223 1.3× 775 5.9× 96 0.8× 40 0.3× 48 1.3k

Countries citing papers authored by D. F. Larson

Since Specialization
Citations

This map shows the geographic impact of D. F. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. F. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. F. Larson more than expected).

Fields of papers citing papers by D. F. Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. F. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. F. Larson. The network helps show where D. F. Larson may publish in the future.

Co-authorship network of co-authors of D. F. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of D. F. Larson. A scholar is included among the top collaborators of D. F. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. F. Larson. D. F. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Marchalonis, John J., et al.. (2005). Immunomodulation by Immunopeptides and Autoantibodies in Aging, Autoimmunity, and Infection. Annals of the New York Academy of Sciences. 1057(1). 247–259. 7 indexed citations
2.
Huang, Mengting, Joseph J. Bahl, Yuhong Wu, et al.. (2005). Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. American Journal of Physiology-Heart and Circulatory Physiology. 288(2). H497–H503. 39 indexed citations
3.
Yang, Bo, et al.. (2000). Conductivity: An issue for the application of the conductance catheter system in mice. 5(1). 57–60. 8 indexed citations
4.
Larson, D. F., et al.. (1992). Session IX: Social and ethical controversies in pediatric heart transplantation.. PubMed. 10(5 Pt 2). 860–76. 3 indexed citations
5.
Neidhart, Michel & D. F. Larson. (1990). Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones. Journal of Neuroimmunology. 26(2). 97–105. 33 indexed citations
6.
Russell, Diane H., Ruthann Kibler, Lynn M. Matrisian, et al.. (1985). Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.. The Journal of Immunology. 134(5). 3027–3031. 291 indexed citations
7.
Meijboom, Erik J., S Horowitz, Lilliam M. Valdes‐Cruz, et al.. (1985). A Doppler echocardiographic method for calculating volume flow across the tricuspid valve: correlative laboratory and clinical studies.. Circulation. 71(3). 551–556. 57 indexed citations
8.
Larson, D. F., et al.. (1984). Cyclosporin A and methylprednisolone may regulate immune function through the modulation of prolactin release. Federation Proceedings. 43(4). 2 indexed citations
11.
Valdes‐Cruz, Lilliam M., S Horowitz, David J. Sahn, et al.. (1983). A pulsed Doppler echocardiographic method for calculation of pulmonary and systemic flow: accuracy in a canine model with ventricular septal defect.. Circulation. 68(3). 597–602. 52 indexed citations
12.
Meijboom, Erik J., Lilliam M. Valdes‐Cruz, S Horowitz, et al.. (1983). A two-dimensional Doppler echocardiographic method for calculation of pulmonary and systemic blood flow in a canine model with a variable-sized left-to-right extracardiac shunt.. Circulation. 68(2). 437–445. 44 indexed citations
13.
Fisher, Daniel C., David J. Sahn, Mark J. Friedman, et al.. (1983). The effect of variations of pulsed Doppler sampling site on calculation of cardiac output: an experimental study in open-chest dogs.. Circulation. 67(2). 370–376. 95 indexed citations
14.
Womble, J. R., D. F. Larson, Jack G. Copeland, & Diane H. Russell. (1982). Low-dose oral terbutaline therapy rapidly induces significant cardiac hypertrophy. Clinical Pharmacology & Therapeutics. 31(2). 2 indexed citations
15.
Larson, D. F., J. R. Womble, & Jack G. Copeland. (1981). Plasma epinephrine levels predict right ventricular hypertrophy. Federation Proceedings. 40. 1 indexed citations
16.
Womble, J. R., D. F. Larson, & B. R. Brown. (1981). A-16. Isoproterenol acts directly on myocardial β-receptors to cause cardiac hypertrophy. Clinical Pharmacology & Therapeutics. 29(2). 289–290. 1 indexed citations
17.
Larson, D. F.. (1981). Epinephrine regulates compensatory right and left ventricular hypertrophy. Journal of Molecular and Cellular Cardiology. 13. 48–48. 1 indexed citations
18.
Womble, J. R., D. F. Larson, Jack G. Copeland, et al.. (1980). Adrenal medulla denervation prevents stress-induced epinephrine plasma elevation and cardiac hypertrophy. Life Sciences. 27(24). 2417–2420. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026